Kerlikowske K, Smith-Bindman, Ljung BM, et al. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med 2003;139:274–284.
71.
Brazda A, Estroff J. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol 2010;17:291–296.
72.
Abati A, Simsir A. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices. Clin Lab Med 2005;25:631–654.
73.
Morris AM, Flowers CR. Comparing the cost effectiveness of the triple test score to traditional methods for evaluating palpable breast masses. Med Care 2003;41:962–971.
74.
Ahmed I, Nazir R, Chaudhary MY, et al. Triple assessment of breast lump. J Coll Physician Surg 2007;17:535–538.
75.
Ciatto S, Houssami N. Breast imaging and needle biopsy in women with clinically evident breast cancer: does combined imaging change overall diagnostic sensitivity? Breast 2007;16:382–386.
76.
Vimpeli SM, Saarenmaa I, Huhtula H, et al. Large-core needle biopsy versus fine needle aspiration biopsy in solid breast lesions: comparison of cost and diagnostic value. Acta Radiol 2008;49:863– 869.
77.
Kuo YL, Chang TW. Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions? BMC Cancer 2010;10:371–377.
78.
Ellis I, Humphreys M, Michell M, et al. Best Practice No. 179: guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 2005;57:897–902.
79.
Blaylock RC, Byrne JLB, Clayton F, et al. The Internet pathology laboratory for medical education. Available online at: http://202.193.198.50/glblnet/severbj1/bl/WEBPATH.HTM 80.
Ciampa A, Xu B, Bayiee D, et al. HER-2 status in breast cancer; correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. Appl Immunohistochem Mol Morphol 2006;14:132–137.
81.
Vaugh A, Crowe JP. Mammary ductoscopy and ductal washings for the evaluation of patients with pathologic nipple discharge. Breast 2009;15:254–260.
82.
Courtillot C, Plu-Bureau, Binart N, et al. Benign breast diseases. J Mammary Gland Bio Neoplasia 2005;10:325–335.
83.
Santen RJ, Mansel R. Benign breast disorder. N Engl J Med 2005;353:275–285.
84.
Berg Wa, Sechin AG, Marques H, et al. Cystic breast masses and the ACRIN 6666 experience. Radiol Clin North Am 2010;48:931– 987.
85.
Schindler AE. Non-contraceptive benefits of hormonal contraceptives. Minerva Ginecol 2010;62:319–329.
86.